v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
OPERATING EXPENSES-        
RESEARCH AND DEVELOPMENT EXPENSES $ 418,207 $ 2,175,245 $ 1,220,309 $ 3,661,633
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 1,789,315 2,550,848 3,754,448 4,538,657
Total operating expenses 2,207,522 4,726,093 4,974,757 8,200,290
OPERATING LOSS (2,207,522) (4,726,093) (4,974,757) (8,200,290)
OTHER INCOME (EXPENSE), NET        
Interest income 2,531 45,243 16,355 96,253
Interest expense (1,374,045) (716,814) (2,557,844) (740,251)
Loss on debt settlements 0 0 (728,298) 0
Total other expense, net (1,371,514) (671,571) (3,269,787) (643,998)
LOSS BEFORE INCOME TAXES (3,579,036) (5,397,664) (8,244,544) (8,844,288)
Income tax expense 0 0 0 0
NET LOSS (3,579,036) (5,397,664) (8,244,544) (8,844,288)
Deemed dividends on Series C and D Preferred Stock (23,662) (98,609) (56,214) (162,238)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (3,602,698) $ (5,496,273) $ (8,300,758) $ (9,006,526)
Basic and diluted loss per share $ (1.24) $ (2.69) $ (2.95) $ (4.42)
Weighted average shares of common stock outstanding- basic and diluted (1) 2,909,985 2,044,153 2,809,757 2,035,706

Source